Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances-Reference-Cited by-同舟云学术

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Published:2014-03 Issue:3 Volume:9 Page:295-306
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Cabillic Florian,Gros Audrey,Dugay Frédéric,Begueret Hugues,Mesturoux Laura,Chiforeanu Dan Cristian,Dufrenot Leila,Jauffret Vincent,Dachary Dominique,Corre Romain,Lespagnol Alexandra,Soler Gwendoline,Dagher Julien,Catros Véronique,Le Calve Michèle,Merlio Jean-Philippe,Belaud-Rotureau Marc-Antoine

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference50 articles.

1. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007

2. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

3. Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology;Ou;Oncologist,2012

4. Differential protein stability and ALK inhibitor sensitivity of EML4-ALK fusion variants;Heuckmann;Clin Cancer Res,2012

5. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study;Camidge;Lancet Oncol,2012

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discordant ALK Status in Non-Small Cell Lung Carcinoma: A Detailed Reevaluation Comparing IHC, FISH, and NGS Analyses;International Journal of Molecular Sciences;2024-07-26

2. Shifting from Immunohistochemistry to Screen for ALK Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer;Cancers;2024-06-14

3. Diagnosis and treatment of anaplastic lymphoma kinase (ALK) rearranged non−small cell lung cancer;Lung Cancer;2024

4. Concordance of Immunohistochemistry and Fluorescence In Situ Hybridization in the Detection of Anaplastic Lymphoma Kinase (ALK) and Ros Proto-oncogene 1 (ROS1) Gene Rearrangements in Non–Small Cell Lung Carcinoma: A 4.5-Year Experience Highlighting Challenges and Pitfalls;Archives of Pathology & Laboratory Medicine;2023-12-06

5. Novel ALK immunohistochemistry assay (clone OTI1A4, Dako) is a sensitive, reliable marker for identifying ALK rearrangements in lung adenocarcinomas: A validation study;American Journal of Clinical Pathology;2023-09-08